acut
viral
infect
rapid
immun
respons
occur
infect
host
viral
pathogen
resolut
involv
either
viral
clearanc
host
memori
host
death
due
overwhelm
inflamm
andor
extens
viremia
transit
chronic
infecti
state
unlik
acut
virus
chronic
virus
persist
semist
relationship
within
host
gener
antigen
stimul
sever
month
decad
chronic
viral
infect
categor
latent
lack
substanti
viral
product
initi
late
stage
product
persist
viral
product
begin
late
stage
slow
infect
increas
viral
product
incub
period
late
stage
figur
stage
establish
restrict
viral
propag
reprogram
viral
gene
express
conjunct
viral
adapt
host
control
immun
respons
prevent
overwhelm
chronic
inflamm
could
otherwis
becom
harm
variou
tissu
endur
hyperantigenemia
even
low
undetect
level
occur
persist
viral
infect
impos
perman
stress
immun
system
magnitud
tcell
respons
follow
initi
infect
substanti
essenti
expand
cell
die
antigen
clearanc
maintain
lymphoid
homeostasi
howev
effici
memori
pool
persist
select
cell
escap
apoptosi
must
retain
suffici
replic
potenti
allow
success
round
prolifer
respons
antigen
recal
throughout
host
life
unlik
normal
memori
cell
persist
due
level
exhaust
cell
requir
presenc
viral
antigen
continu
prolifer
partli
due
loss
receptor
limit
gener
virusspecif
cell
viral
antigen
intermitt
constantli
suppli
cell
viralspecif
cell
never
ceas
prolifer
depend
length
infect
could
result
progress
shorter
telomer
agerel
declin
tcell
respons
averag
telomer
length
naiv
cell
kb
longer
effector
memori
cell
would
easi
infer
clonal
expans
memori
cell
distinct
replic
disadvantag
compar
earli
effector
cell
due
theoret
loss
telomer
sequenc
follow
initi
encount
antigen
howev
appear
case
antigenspecif
b
cell
upregul
telomeras
activ
initi
respons
acut
infect
therebi
preserv
clonal
potenti
initi
memori
cell
subsequ
encount
howev
despit
preserv
telomer
length
telomeras
activ
retain
resolut
acut
viral
infect
endur
antigenspecif
cell
suscept
telomer
defect
includ
senesc
death
subsequ
clonal
expans
prolifer
figur
averag
peripher
blood
mononuclear
cell
pbmc
lose
bp
telomer
dna
per
year
loss
potenti
increas
chronic
viral
infect
case
patient
receiv
antiretrovir
treatment
art
loss
bp
per
year
telomer
dna
document
somat
cell
like
effector
memori
cell
finit
prolif
capac
due
larg
inabl
dna
polymeras
replic
distal
end
chromosom
pluripot
stem
cell
major
cancer
cell
circumv
problem
upregul
telomeras
revers
transcriptas
retrograd
add
six
base
pair
ttaggg
nucleotid
sequenc
onto
end
chromosom
cellular
replic
absenc
telomeras
express
result
progress
telomer
shorten
eleg
studi
demonstr
singl
dysfunct
telomer
suffici
caus
telomer
end
replic
problem
increas
chromosom
instabl
degrad
fusion
dysfunct
telomereinduc
foci
tif
engag
dna
damag
respons
ddr
trigger
activ
atm
serinethreonin
kinas
atm
senesc
program
figur
unlik
somat
cell
cell
includ
memori
reactiv
telomeras
mitogen
stimul
cell
initi
harbor
nearli
undetect
level
telomeras
upon
antigen
stimul
case
acut
viral
infect
telomeras
reactiv
process
reiter
second
antigen
stimul
third
subsequ
stimul
cell
less
respons
mitogen
stimul
telomeras
gene
promot
inactiv
deleteri
consequ
excess
telomer
shorten
prematur
induct
replic
senesc
cell
senesc
cell
unabl
expand
surviv
extend
period
time
occupi
immunolog
space
function
immun
cell
could
exist
accumul
senesc
cell
propos
play
role
fail
immun
surveil
facilit
develop
metastasi
certain
cancer
type
interestingli
studi
propos
may
possibl
revers
phenotyp
reactiv
telomeras
express
immun
senesc
cell
bear
sever
trademark
shorten
telomer
decreas
tcellspecif
surfac
tcell
activ
antigen
coreceptor
tcell
activ
increas
loss
prolifer
cell
may
termin
differenti
serv
marker
highli
differenti
cell
cell
usual
undergon
cell
divis
increas
risk
activationinduc
cell
death
increas
individu
chronic
immun
activ
believ
either
phenotyp
lead
senesc
loss
replic
cell
bear
marker
fact
hallmark
senesc
increas
age
seen
lymphocyt
healthi
elderli
individu
suggest
diminish
replic
potenti
cell
loss
often
preclud
express
mark
termin
differenti
cell
accumul
cell
occur
normal
age
chronicantigen
stimul
cell
shorten
telomer
lower
telomeras
activ
less
differenti
cell
loss
delay
hivspecif
cell
transduc
telomeras
suggest
telomer
dynam
provid
intracellular
signal
extinct
express
consequ
accumul
cell
lose
function
reduc
express
effector
molecul
granzym
b
perforin
reduc
cytotox
tlymphocyt
ctl
activ
cell
found
variou
chronic
viral
infect
hiv
viru
ebv
hepat
c
viru
hcv
viralspecif
cell
respond
vari
degre
differenti
phenotyp
addit
marker
senesc
cell
increas
express
killer
cell
lectinlik
receptor
similar
express
surfac
nk
cell
antigenexperienc
cell
lead
defect
signal
prolifer
highli
differenti
cell
critic
telomer
shorten
induc
dna
damag
respons
ddr
dna
damag
repair
either
program
cell
death
apoptosi
replic
senesc
occur
absenc
apoptosi
cell
harbor
dysfunct
telomer
risk
develop
genom
defect
numer
chromosom
instabl
dna
delet
amplif
aneuploidi
cell
progress
senesc
apoptot
marker
found
low
express
antiapoptot
gene
bcell
clllymphoma
upregul
cell
death
marker
tumor
necrosi
factor
receptor
superfamili
member
lead
cell
death
exampl
hivspecif
cell
undergon
replic
senesc
defin
loss
prolif
capac
shorter
telomer
found
sensit
apoptosi
cell
chemokin
receptor
type
defici
harbor
express
therefor
may
termin
differenti
express
believ
make
cell
suscept
activationinduc
cell
death
apoptosi
appear
case
replic
senesc
cell
undergo
apoptosi
contradict
expound
upon
apoptot
resist
acquir
alter
differenti
state
chronic
stimul
mani
subpopul
cell
exist
within
individu
senesc
cell
set
prone
apoptosi
progress
despit
find
enhanc
resist
apoptosi
replic
senesc
cell
often
seen
larg
popul
termin
differenti
nonfunct
cell
found
elderli
human
indic
cell
undergo
senesc
elimin
replic
senesc
perman
overcom
addit
phorbol
pma
ionomycin
antigen
stimul
addit
cell
often
resist
apoptot
signal
dysregul
fasmedi
signal
vitrobas
studi
shown
repeat
antigen
encount
lead
resist
activationinduc
cell
death
cell
increas
signal
phosphatas
tensin
homolog
pten
loss
lead
impair
activ
cell
expos
longterm
antigen
also
show
increas
express
bclxl
reduc
express
proapoptot
protein
bad
bax
like
less
differenti
state
prone
apoptosi
late
differenti
cell
acquir
apoptosi
resist
lead
replic
senesc
tcell
exhaust
state
wherebi
normal
tcell
function
impair
consequ
chronic
antigen
stimul
detail
tcell
exhaust
still
defin
includ
impair
memori
cell
impair
tcell
effector
respons
impair
tcell
respons
resist
apoptosi
acceler
immun
senesc
figur
theori
tcell
function
exhaust
chronic
viral
infect
origin
describ
chronic
lymphocyt
choriomening
viru
lcmv
infect
mice
unlik
acut
viral
infect
lcmv
viral
isol
persist
within
host
caus
lethal
therebi
mimick
chronic
infect
host
ctl
respons
disappear
follow
infect
chronic
strain
lcmv
origin
propos
advoc
viru
never
effect
clear
cell
overwhelm
fight
viru
ctl
respons
elimin
entir
clear
exhaust
cell
show
progress
loss
antivir
function
prolif
capac
diminish
follow
sequenti
loss
product
cytolyt
kill
decreas
tumor
necrosi
factor
tnf
interferongamma
product
diminish
degranul
result
clonal
delet
dampen
cytolyt
respons
chronic
viral
infect
shown
viralspecif
cell
hiv
ebv
cytomegaloviru
cmv
infect
includ
loss
perforin
along
granzym
proteas
vital
ctl
abil
elimin
antigenpres
cell
control
level
activ
cell
apoptosi
chronic
infect
also
extens
profil
gene
dysregul
exhaust
cell
effector
cell
includ
defect
host
cell
signal
molecul
calcium
bind
cytokin
signal
apoptosiscel
death
migrat
impair
ctl
function
attribut
part
presenc
coinhibitori
marker
part
normal
yet
transient
respons
acut
infect
inhibitori
marker
serv
dampen
inhibit
immun
respons
continu
express
surfac
exhaust
cell
advanc
stage
tcell
exhaust
mark
damp
tcell
effector
function
occur
inhibitori
marker
found
surfac
cell
along
greater
varieti
inhibitori
marker
express
wellknown
highli
express
inhibitori
marker
exhaust
cell
program
death
receptor
member
costimulatori
famili
modul
tcell
respons
infect
reduc
ctl
effector
decreas
prolifer
specif
effector
memori
cell
addit
marker
found
exhaust
cell
includ
naturalkil
cell
receptor
tcell
immunoglobulin
mucin
natur
killer
receptor
famili
member
lymphocyteactiv
gene
cytotox
tlymphocyteassoci
prostaglandin
e
receptor
possess
immunotyrosin
inhibitori
motif
switch
decreas
activ
cell
signal
exhaust
cell
exampl
prevent
effector
respons
express
tnf
turn
advers
effect
nontcel
popul
dendrit
cell
natur
killer
cell
nk
macrophag
import
note
studi
inhibitori
marker
carri
use
lcmv
model
mice
thirteen
inhibitori
receptor
found
differenti
regul
exhaust
cell
may
repres
complet
descript
human
cell
instanc
mous
glycoprotein
upregul
exhaust
cell
human
homolog
yet
identifi
less
known
tcell
exhaust
cell
clear
exhaust
cell
alter
phenotyp
compar
effector
memori
cell
exhaust
cell
express
similar
inhibitori
marker
transcript
factor
counterpart
cell
includ
express
higher
ratio
inhibitori
marker
b
tlymphocyt
associ
protein
btla
exhaust
cell
diminish
respons
alter
effector
function
latter
relat
distinct
transcript
program
regulatori
cell
treg
also
alter
function
chronic
viral
infect
chronic
viral
infect
lead
upregul
surfac
treg
enhanc
treg
prolifer
allow
greater
inhibitori
function
cell
addit
express
surfac
treg
aid
enhanc
immun
suppress
action
exhaust
cell
found
individu
infect
multitud
human
chronic
virus
mice
lcmv
describ
telomer
shorten
viralspecif
cell
hierarch
rank
system
antigen
produc
telomer
shorten
faster
rate
antigen
cmv
infect
seem
take
highest
spot
hierarchi
differenti
state
shorter
telomer
viru
hiv
ebv
hcv
yet
confirm
one
could
infer
viral
infect
lead
extens
exhaust
state
would
prone
faster
telomer
shorten
immun
senesc
hiv
infect
cell
respons
acquir
immun
defici
syndrom
aid
due
advanc
antiretrovir
therapi
art
hivinfect
individu
live
longer
chronic
hiv
infect
immun
system
bear
strike
resembl
otherwis
healthi
elderli
peopl
higher
incid
infect
loss
effector
function
despit
fact
precipit
drop
infecti
hiv
acut
chronic
phase
hiv
antigen
come
hiv
particl
later
stage
suggest
consequ
art
hivspecif
cell
expos
viral
antigen
longer
period
time
lead
increas
hivspecif
tcell
exhaust
possibl
immun
senesc
inde
marker
tcell
exhaust
immun
senesc
document
hivinfect
individu
includ
enhanc
express
inhibitori
marker
reduct
effector
cytokin
reduc
prolif
selfrenew
potenti
lack
tcell
help
fact
express
correl
impair
tcell
function
reduc
cell
increas
viral
load
sensit
cell
apoptosi
signific
hivinduc
apoptosi
uninfect
bystand
cell
contribut
hivassoci
tcell
death
diseas
progress
process
complet
understood
signific
interplay
tcell
exhaust
hiv
diseas
demonstr
fact
aggress
form
diseas
harbor
cell
advanc
tcell
exhaust
therapi
reduc
exhaust
phenotyp
lead
increas
tcell
effector
function
reduct
viru
load
art
treatment
effect
control
tcell
count
viremia
unintend
consequ
rise
tcell
level
cell
link
increas
complic
nonaidsrel
malign
research
discov
increas
immun
senesc
phenotyp
cell
cmvspecif
due
fact
chronic
hiv
infect
increas
viralspecif
nonhiv
cell
fact
hivspecif
cell
intermedi
phenotyp
still
express
anoth
report
determin
increas
hivspecif
cell
serv
better
marker
immun
senesc
sinc
correl
replic
capac
hivspecif
cell
suscept
apoptosi
point
gener
trend
cell
regardless
infecti
state
express
indic
cellular
divis
result
shorter
telomer
major
consequ
harbor
hivexhaust
cell
prematur
age
accord
immun
senesc
cell
found
hivinfect
individu
telomer
length
differenti
cell
significantli
shorter
hivinfect
noninfect
individu
cell
poor
replic
potenti
character
immunosenesc
howev
determin
hiv
specif
made
necess
sinc
longterm
expand
cell
known
shorter
telomer
undergo
replic
senesc
normal
individu
phenomenon
also
seen
matur
individu
children
age
year
infect
hiv
children
harbor
shorter
telomer
length
higher
proport
senesc
cell
appear
specif
cell
sinc
cell
senesc
even
though
express
higher
level
likewis
comparison
telomeras
telomer
length
popul
hiv
set
twin
demonstr
increas
telomer
length
cell
decreas
telomer
length
cell
cell
hiv
twin
retain
replic
potenti
despit
fact
telomeras
activ
remain
low
undetect
popul
cell
suggest
cell
undergo
replic
senesc
hiv
infect
howev
fact
cell
demonstr
shorter
telomer
line
tcell
senesc
though
studi
one
cell
sort
hivspecif
memori
cell
apposit
support
telomer
shorten
hivspecif
exhaust
cell
result
studi
character
telomer
dynam
hiv
progressor
hiv
control
reduct
telomer
length
hivspecif
cell
demonstr
hiv
progressor
hiv
progressor
hivspecif
cell
reduc
telomeras
activ
telomer
length
shorter
comparison
cell
specif
hiv
control
also
cmv
ebv
bulk
cell
person
pathway
block
telomeras
activ
telomer
length
increas
hivspecif
cell
progressor
determin
role
telomer
shorten
limit
tcell
replic
hiv
cell
transduc
telomeras
telomeras
addit
result
increas
hiv
target
reduct
level
like
hiv
hepat
b
c
hbv
hcv
virus
product
chronic
virus
display
tcell
exhaust
telomer
shorten
hbv
hcv
major
caus
acut
liver
infect
howev
hbv
hcv
respons
larg
proport
global
chronic
liver
diseas
anywher
hbv
hcv
infect
rerout
chronic
infect
delay
immun
respons
everchang
viral
mutat
landscap
allow
viru
adapt
persist
especi
hcv
infect
fact
chronic
viral
liver
diseas
nearli
complet
due
adapt
immun
respons
immunopatholog
consist
lowlevel
ctl
respons
destroy
hepatocyt
lead
liver
cirrhosi
hepatocellular
carcinoma
hcc
telomer
length
measur
hbv
hcv
infect
perform
host
cell
hepatocyt
telomer
length
found
shorter
hepatocyt
chronic
hcv
infect
especi
hcc
lead
chromosom
instabl
studi
replic
senesc
hcvspecif
cell
difficult
due
rel
scarciti
hcvspecif
cell
peripheri
despit
difficulti
abund
data
support
notion
telomer
attrit
occur
total
cell
chronic
hbv
hcv
infect
telomeras
rna
level
found
lower
peripher
blood
lymphocyt
pbl
hbv
hcvinfect
individu
may
contribut
immunosuppress
telomer
length
assess
hcc
patient
infect
hbv
hcv
demonstr
shorter
telomer
length
liver
biopsi
tissu
also
pbl
telomer
attrit
seen
hbvhcvnoninfecti
hcc
suggest
longterm
hbvhcv
infect
caus
advers
effect
telomer
length
pbl
support
chronic
hcv
patient
shorter
telomer
cell
memori
phenotyp
telomer
length
compar
normal
age
year
enhanc
year
sever
fibrosi
diseas
telomer
shorten
found
cellfre
serum
dna
chronic
hbv
infect
telomer
length
follow
year
individu
infect
hcv
dual
hcvhiv
research
found
differ
telomer
length
compar
length
nonhcvinfect
individu
telomer
length
cell
shorter
hcvinfect
individu
shorter
cell
dual
infect
telomer
length
correl
differenti
cell
owe
possibl
length
measur
taken
total
pbmc
patient
sort
viralspecif
cell
among
gene
alter
chronic
hbv
infect
telomer
repeat
bind
factor
interact
protein
known
regul
telomer
dynam
express
decreas
hbvspecif
cell
addit
express
gene
associ
cellular
senesc
found
downregul
exhaust
hbvspecif
cell
includ
atm
sever
dna
repair
protein
rad
protein
polh
dna
polymeras
eta
polymeras
involv
transles
repair
earli
exposur
life
hbv
infect
possibl
lead
shorter
telomer
length
cell
earli
develop
immunosenesc
indirect
measur
hbv
infect
perform
individu
live
hbv
endem
area
hcc
develop
high
tcell
immun
marker
hbv
infect
individu
also
demonstr
low
tcell
count
suggest
immun
impair
longterm
exposur
hbv
chronic
hcv
patient
cell
shown
shorter
telomer
hallmark
dna
damag
includ
marker
dna
doublestrand
break
serin
phosphoryl
immun
impair
seen
cell
fail
signal
jakstat
signal
pathway
major
cell
highli
differenti
either
phenotyp
express
possibl
owe
fact
hcvspecif
cell
analyz
could
cell
sinc
hcvspecif
could
owe
phenotyp
bystand
effect
secret
prodifferenti
factor
releas
cours
chronic
viral
infect
describ
cmv
infect
releas
interferonalpha
caus
cmvspecif
cell
differenti
lose
telomer
length
releas
respons
cmv
infect
inhibit
telomeras
activ
lead
telomer
shorten
direct
examin
telomer
length
senesc
examin
hbv
hcv
specif
cell
suggest
telomer
dynam
slow
replic
alter
exhaust
hbvspecif
cell
exhaust
viralspecif
cell
describ
hbv
hcv
exhaust
hcvspecif
cell
found
liver
spleen
blood
exhaust
inhibitori
receptor
phenotyp
vari
accord
inhibitori
marker
level
express
receptor
upregul
effector
memori
cell
marker
activ
state
hbv
acut
infect
low
express
seen
exhaust
cell
chronic
viral
infect
hiv
hcvspecif
cell
express
low
high
inhibitori
marker
impair
prolifer
seen
could
reinvigor
block
addit
blockad
enhanc
tcell
prolifer
ctl
respons
present
surfac
chronic
infect
hcv
cell
also
present
conjunct
given
coloc
two
marker
cell
suggest
chronic
hcv
infect
exhaust
cell
undergo
senesc
less
axiomat
viralspecif
tcell
exhaust
latent
viral
infect
includ
whether
latent
viral
infect
lead
shorten
telomer
replic
senesc
andor
apoptosi
major
studi
tcell
exhaust
perform
lcmv
model
though
correctli
depict
chronic
product
virus
accur
reflect
chronic
latent
virus
often
virus
hidden
immun
surveil
andor
produc
low
abund
viral
antigen
studi
use
adapt
influenza
viru
mimic
chronic
antigen
stimul
shown
tcell
exhaust
still
occur
model
allow
absenc
larg
viral
load
lymphocyt
infect
demonstr
tcell
exhaust
albeit
alter
mechan
evid
tcell
exhaust
andor
senesc
found
latent
chronic
viral
infect
outlin
still
larg
gap
research
describ
telomer
dynam
infect
major
chronic
latent
virus
discuss
known
oncogen
demonstr
alter
telomeras
activ
shorter
telomer
infect
cell
howev
ebv
studi
demonstr
telomer
attrit
ebvspecif
cell
highlight
fact
studi
need
done
examin
relationship
longterm
chronic
viral
infect
effect
viralspecif
immun
respons
regard
telomer
attrit
senesc
addit
hindranc
studi
tcell
exhaust
downstream
effect
latent
viral
infect
lack
data
owe
endem
natur
virus
challeng
remain
find
noninfect
cell
worldwid
endem
latent
virus
exampl
order
measur
tcell
exhaust
telomer
length
varicella
zoster
viru
vzv
specif
cell
nonvzv
cell
requir
comparison
estim
number
infect
individu
vzv
temper
climat
without
vaccin
therefor
find
individu
without
longterm
vzv
circul
cell
difficult
despit
constraint
hallmark
tcell
exhaust
found
two
characterist
latent
virus
vzv
viru
vzvspecif
cell
declin
age
lost
tcell
function
express
tcell
exhaust
marker
vivo
model
also
demonstr
exist
hsv
tcell
exhaust
cell
compar
time
telomer
length
vzv
hsvspecif
cell
significantli
shorten
senesc
observ
may
result
fact
vzv
present
major
antigen
attract
due
high
abil
bypass
immun
system
locat
latent
viral
reservoir
one
patient
vzvspecif
tcell
prolifer
telomer
length
actual
increas
period
shingl
though
singl
case
larger
studi
may
demonstr
reactiv
viru
latenc
induc
telomer
elong
cell
like
newli
activ
effector
cell
longer
telomer
convert
new
memori
cell
vzv
hsv
effect
hidden
immun
surveil
due
locat
neuron
human
tcell
leukemia
viru
htlvi
infect
cell
immun
system
therefor
abil
avoid
immun
surveil
limit
addit
unlik
vzv
htlvi
endem
popul
htlvi
like
hiv
retroviru
infect
predominantli
cell
respons
two
differ
diseas
invari
fatal
tcell
cancer
adult
tcell
leukemialymphoma
atll
neurodegen
diseas
tropic
spastic
paraparesishtlviassoci
myelopathi
tspham
atll
develop
long
latenc
period
sever
decad
individu
infect
htlvi
latenc
period
shorter
tspham
direct
examin
telomer
length
htlvispecif
cell
perform
sever
piec
data
describ
argu
replic
senesc
occur
cell
includ
long
latenc
period
htlvi
upregul
inhibitori
marker
loss
effector
tcell
function
differentiatedsenesc
phenotyp
seen
htlvi
cell
profound
tcell
dysfunct
found
htlvspecif
cell
htlvispecif
cell
found
htlv
carrier
atl
tsp
patient
prevail
theori
dysfunct
ctl
respons
htlv
viru
particular
immunodomin
viral
antigen
tax
may
lead
reduc
elimin
htlvi
cell
host
atl
progress
case
tsp
reduc
ctl
function
may
promot
diseas
symptom
htlviinfect
patient
demonstr
lack
recal
respons
highli
immunogen
antigen
tspham
htlviinfect
asymptomat
carrier
htlvi
tax
specif
cell
found
carrier
tspham
atl
patient
howev
atl
patient
demonstr
significantli
less
taxspecif
cell
viral
state
stimul
ex
vivo
tax
tspham
patient
carrier
abl
prolifer
produc
howev
prolifer
sever
impair
atl
small
percentag
htlvi
carrier
fact
viralspecif
cell
found
lower
ctl
activ
lower
perforin
granzym
b
along
lower
express
immun
costimulatori
molecul
tsp
patient
case
atl
profound
immun
disrupt
found
atl
patient
includ
reduc
cell
harbor
epitop
immunogen
viral
antigen
lower
ctl
activ
increas
tcell
exhaust
marker
report
htlviinfect
cell
htlvi
carrier
diseas
individu
htlvi
viral
protein
also
increas
express
inhibitori
molecul
express
coinhibitori
marker
cell
immunoglobulin
itim
domain
tigit
increas
viral
protein
suppress
tcell
respons
tigit
found
express
cell
atl
tsp
patient
block
either
tigit
led
enhanc
immun
respons
htlvi
tsp
patient
along
tigit
inhibitori
marker
demonstr
play
function
htlviinfect
cell
includ
block
pathway
cell
led
increas
tcell
cytotox
function
includ
enhanc
express
inhibit
signal
result
improv
function
htlvispecif
cell
increas
perforin
express
tspham
patient
also
display
higher
level
cell
opposit
function
inhibit
degranul
cell
tsp
patient
also
defici
express
latter
indic
termin
differenti
htlvspecif
cell
tsp
patient
express
late
differenti
phenotyp
wherea
htlvspecif
cell
htlv
carrier
intermedi
phenotyp
sever
studi
report
characterist
associ
senesc
phenotyp
htlvi
infect
impair
cell
abil
prolifer
respons
antigen
stimul
increas
level
proinflammatori
prosenesc
cytokin
reduc
express
vitro
taxspecif
cell
tspham
patient
also
display
phenotyp
effector
memori
cell
termin
differenti
effector
memori
cell
atl
patient
known
harbor
shorten
telomer
defect
telomeras
express
total
pbmc
short
telomer
htlviinfect
cell
recogn
dna
doublestrand
break
activ
ddr
pathway
elev
atm
activ
culmin
replic
senesc
howev
role
telomer
dysfunct
senesc
htlvspecif
cell
never
investig
patient
whether
senesc
phenotyp
seen
htlvi
diseas
due
telomer
attrit
someth
els
oxid
damag
studi
htlvispecif
viral
memori
cell
similar
htlvi
viru
ebv
chronic
latent
viru
oncogen
link
sever
cancer
estim
nearli
world
popul
infect
ebv
ebv
respons
wide
plethora
human
diseas
includ
associ
defect
b
cell
acut
infecti
mononucleosi
aim
wide
varieti
nonbcel
diseas
given
preval
ebv
infect
popul
like
individu
harbor
ebvspecif
cell
studi
shown
express
ebv
cell
healthi
individu
increas
ebv
cell
ebv
monoinfect
ebvhiv
coinfect
high
express
also
found
ebv
cell
ebvhiv
coinfect
individu
level
express
ebv
cell
nearli
equal
hiv
cell
ebv
diffus
larg
bcell
lymphoma
dlbcl
administr
caus
enhanc
prolifer
cytokin
express
restor
antitumor
immun
ebv
exhaust
cell
also
link
emerg
sever
condit
wide
varieti
ebvassoci
diseas
includ
chronic
fatigu
syndrom
cf
multipl
sclerosi
ms
system
lupu
erythematosu
sle
sign
ebvspecif
tcell
exhaust
includ
elev
decreas
cytotox
tcell
function
ebv
cell
sle
diminish
bcell
memori
respons
cf
reduc
ebv
tcell
function
exhaust
ms
also
found
elev
ebvposit
hl
ptld
latter
shown
ebv
latent
gene
product
could
elev
gene
promot
express
clearer
understand
effect
telomer
dynam
chronic
ebv
infect
came
studi
ebvspecif
cell
aim
immedi
follow
aim
ebvspecif
cell
abl
prevent
telomer
eros
upregul
telomeras
major
individu
telomer
length
remain
unchang
immedi
follow
aim
howev
longitudin
studi
infect
patient
month
year
mark
telomer
attrit
note
ebvspecif
cell
cell
continu
expos
ebv
antigen
unabl
upregul
telomeras
fact
longterm
clone
ebvspecif
cell
decreas
time
suggest
chronic
ebv
exposur
lead
replic
senesc
ebv
cell
situat
ebv
infect
control
research
examin
telomer
dynam
chronic
ebv
infect
replic
often
occur
hivinfect
immunocompromis
individu
fact
aidsrel
nonhodgkin
lymphoma
aidsnhl
thought
evolv
due
accumul
ebvspecif
cell
lost
cytotox
immun
function
ie
exhaust
longer
abl
control
ebv
infect
individu
ebvspecif
cell
show
mark
decreas
telomer
length
seem
preclud
senescentlik
phenotyp
toward
ebv
infect
suggest
due
larg
decreas
ebv
cell
similarli
seen
elderli
similar
situat
occur
xlink
lymphoprolif
syndrom
xlp
inflat
immun
respons
ebv
infect
examin
ebvspecif
cell
survivor
demonstr
loss
telomeras
shorter
telomer
length
differenti
state
unlik
htlv
ebv
infect
littl
inform
regard
telomer
shorten
relat
tcell
exhaust
chronic
viral
infect
case
chronic
kaposi
sarcomaassoci
herpesviru
kshv
infect
also
known
human
human
papilloma
viru
hpv
infect
date
studi
done
examin
tcell
exhaust
senesc
marker
telomer
length
memori
cell
given
fact
tcell
exhaust
found
chronic
viral
infect
conceiv
also
case
patient
patient
kaposi
sarcoma
ks
lower
amount
cell
carrier
seen
hivrel
ks
classic
ks
suggest
global
tcell
dysfunct
diseas
patient
addit
express
natur
killer
cell
nk
ks
patient
stain
also
found
cell
diseas
senesc
marker
decreas
cell
also
found
individu
hivassoci
ks
inform
also
need
replic
senesc
tcell
exhaust
chronic
hpv
infect
howev
low
antigen
load
hpv
infect
like
contribut
fact
tcell
exhaust
may
occur
extent
difficult
detect
hpvinfect
individu
compar
chronic
viral
diseas
longterm
exist
cell
requir
presenc
viral
antigen
surviv
direct
amount
antigen
dictat
tcell
exhaust
hpv
favor
use
nonpref
codon
reduc
frequenc
hpv
viru
antigen
expos
immun
system
inde
hpvspecif
cell
absent
neglig
number
peripher
blood
patient
cervic
cancer
may
result
absenc
cell
infect
area
crossreact
hpv
epitop
pathogen
addit
consider
chronic
latent
virus
viralspecif
cell
may
locat
outsid
blood
stream
case
hpv
hpvspecif
cell
may
absent
peripher
blood
instead
local
mucos
tissu
therefor
telomer
length
measur
tcell
exhaust
marker
may
need
analyz
memori
cell
mucosa
report
studi
suggest
tcell
dysfunct
howev
studi
directli
assess
phenotyp
hpvspecif
cell
ie
inhibitori
marker
cytokin
profil
cell
dendrit
cell
cervic
tissu
posit
highgrad
hpv
infect
seen
conjunct
reduct
helper
cell
also
shown
hpvassoci
recurr
respiratori
papillomatosi
rrp
hpvspecif
cell
dysfunct
decreas
activ
reduc
howev
link
tcell
anergi
exhaust
cell
express
therapi
abl
boost
vaccin
direct
gene
boost
tumorinfiltr
cell
hpvassoci
head
neck
squamou
cell
carcinoma
hnscc
gener
respons
chemotherapi
hpvneg
hnscc
found
hpv
hnscc
increas
express
infiltr
cell
mice
given
vaccin
therapi
express
elev
favor
outcom
howev
cell
like
exhaust
sinc
half
express
hpv
viru
shown
alter
telomer
dynam
viral
protein
hpv
induc
augment
telomeras
express
respect
lead
telomer
attrit
enhanc
chromosom
instabl
infect
cell
seen
cervic
intraepitheli
neoplasia
cin
patient
wherein
telomer
length
significantli
shorter
stage
diseas
activ
ddr
pathway
though
hpvspecif
telomer
dynam
studi
sever
report
demonstr
telomer
attrit
pbl
hpvinfect
individu
hpvinfect
individu
shorter
telomer
length
pbl
greater
risk
develop
oropharyng
squamou
cell
carcinoma
osc
opc
tumor
hpv
seroposit
led
correl
shorter
telomer
length
pbl
esophag
squamou
cell
carcinoma
escc
pbl
head
neck
cancer
patient
also
shown
harbor
shorten
telomer
howev
distinct
hpv
never
made
evid
mount
high
level
antigen
stimul
result
excess
prolifer
drive
cell
state
replic
senesc
due
telomer
attrit
benefit
address
viral
tcell
exhaust
immun
senesc
patient
chronic
viral
infect
chronic
inflammatori
autoimmun
diseas
great
final
erad
chronic
viru
therefor
relev
ongo
effort
develop
therapeut
vaccin
aim
stimul
tcell
respons
current
immunotherapi
base
adopt
transfer
expand
virusspecif
cell
still
mani
question
come
therapeut
potenti
block
tcell
exhaust
one
concern
whether
fulli
exhaust
cell
reactiv
exhaust
cell
reach
state
termin
differenti
may
undergon
perman
cell
cycl
arrest
irrevers
cellular
senesc
case
import
antiexhaust
therapi
drug
block
immun
inhibitori
marker
discuss
given
proper
time
cell
becom
perman
differenti
latter
case
would
imper
target
cell
remov
enhanc
cell
death
sinc
reactiv
possibl
furthermor
subset
cell
expos
chronic
viral
infect
express
tcell
gene
shown
elev
cell
retain
properti
exhaust
memori
cell
cell
may
repres
pole
cell
reactiv
prolifer
chronic
infect
inhibitori
marker
block
anoth
concern
whether
antiexhaust
therapi
fulli
reactiv
viralspecif
pool
memori
cell
whether
exhaust
cell
retain
effector
function
anoth
caveat
determin
mani
immun
inhibitori
receptor
target
shown
extent
upregul
inhibitori
marker
cell
vari
virus
would
easi
infer
differ
therapi
would
less
effect
differ
virus
exampl
drug
target
ipilimumab
approv
food
drug
administr
fda
shown
success
patient
metastat
melanoma
howev
viral
infect
target
led
increas
viral
product
reduct
antivir
therapi
chronic
hcv
infect
therapi
led
small
increas
prolifer
suggest
cocktail
therapi
variou
inhibitori
marker
would
success
use
antibodi
great
effect
simian
version
hiv
simian
immunodefici
siv
cell
increas
blood
led
enhanc
prolifer
effector
function
drop
siv
viral
level
also
shown
effect
vivo
model
hbv
wherebi
block
interact
led
increas
enhanc
effector
function
clear
hbv
viru
fda
alreadi
approv
two
therapi
pembrolizumab
nivolumab
use
metastat
melanoma
use
yet
approv
chronic
viral
infect
ongo
clinic
trial
use
nivolumab
treat
htlviassoci
atl
addit
phase
trial
nivolumab
hpvassoci
squamou
cell
carcinoma
anal
canal
scca
patient
show
complet
partial
respons
patient
combin
therapi
produc
enhanc
abil
control
ebv
infect
lead
reduct
lymphoma
increas
ebv
effector
respons
decreas
ebvinfect
b
cell
addit
evid
block
one
inhibitori
receptor
seen
cancer
nonsmal
cell
lung
cancer
patient
develop
resist
therapi
link
enhanc
cell
surfac
cell
one
target
could
prove
promis
pselectin
glycoprotein
ligand
knockdown
led
improv
antivir
respons
downregul
sever
inhibitori
receptor
includ
btla
blockad
could
therefor
effect
therapeut
target
tcell
exhaust
target
individu
inhibitori
marker
alon
sinc
telomer
attrit
appear
link
longterm
tcell
exhaust
anoth
concern
address
whether
telomeras
therapi
need
ad
addit
antiexhaust
therapi
rebound
exhaust
cell
would
still
critic
shorten
telomer
unabl
upregul
telomeras
telomeras
may
requir
restor
prolif
capac
newli
effect
cell
furthermor
concern
need
address
upcom
studi
regard
tcell
exhaust
immun
senesc
import
limit
studi
previous
perform
chronic
viral
infect
use
total
pbmc
instead
specif
subpopul
use
southern
blot
telomer
restrict
fragment
trf
measur
telomer
length
assay
give
gener
overview
allow
distinct
differ
cellular
subtyp
individu
chromosom
import
singl
chromosom
harbor
critic
short
telomer
initi
senesc
studi
need
repeat
look
individu
chromosom
level
molecular
determin
tcell
exhaust
discov
use
lcmv
infect
mice
interpret
viral
studi
carri
mice
howev
mice
extrem
differ
telomer
dynam
human
one
unlik
human
mice
extrem
long
telomer
second
concern
lifespan
differ
two
speci
human
live
consider
longer
year
mice
year
therefor
effect
progress
tcell
exhaust
telomer
shorten
senesc
far
pronounc
dramat
human
given
shorter
lifespan
often
steril
experiment
laboratori
condit
mice
expos
mani
distinct
pathogen
human
therefor
mice
mani
distinct
viralspecif
longterm
memori
cell
human
hiv
htlv
retrovirus
requir
revers
transcriptas
viral
product
retrovir
therapi
consequ
would
also
target
telomeras
case
telomer
shorten
effect
could
even
greater
viral
infect
reli
upon
revers
transcriptas
prolifer
addit
consider
keep
mind
telomeras
loss
telomer
shorten
describ
immun
senesc
molecular
mechan
respons
shut
telomeras
express
elucid
intrigu
repeat
cellular
stimul
immun
cell
result
transcript
silenc
telomeras
promot
therefor
outcom
telomer
shorten
immun
senesc
may
similar
chronic
infect
cell
subpopul
underli
signal
mechan
involv
worth
investig
understand
regulatori
mechan
control
telomeras
express
chronic
infect
allow
design
specif
target
therapi
may
appli
chronic
stimul
disord
conclus
sustain
antigen
stimul
due
chronic
viral
infect
impos
consider
constraint
immun
system
chronic
prolifer
viralspecif
memori
cell
lead
telomer
shorten
activ
ddr
replic
senesc
tcell
exhaust
occur
lead
loss
ctl
effector
memori
cell
function
constraint
make
difficult
effect
clear
viru
lead
reactiv
viru
later
life
cancer
case
oncogen
virus
diseas
reemerg
host
death
make
allevi
tcell
exhaust
prioriti
antivir
therapi
